BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1079 related articles for article (PubMed ID: 12362409)

  • 1. Update on the glutamatergic neurotransmitter system and the role of excitotoxicity in amyotrophic lateral sclerosis.
    Heath PR; Shaw PJ
    Muscle Nerve; 2002 Oct; 26(4):438-58. PubMed ID: 12362409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid from amyotrophic lateral sclerosis patients preferentially elevates intracellular calcium and toxicity in motor neurons via AMPA/kainate receptor.
    Sen I; Nalini A; Joshi NB; Joshi PG
    J Neurol Sci; 2005 Aug; 235(1-2):45-54. PubMed ID: 15936037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Slow and selective death of spinal motor neurons in vivo by intrathecal infusion of kainic acid: implications for AMPA receptor-mediated excitotoxicity in ALS.
    Sun H; Kawahara Y; Ito K; Kanazawa I; Kwak S
    J Neurochem; 2006 Aug; 98(3):782-91. PubMed ID: 16893420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium-permeable alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors: a molecular determinant of selective vulnerability in amyotrophic lateral sclerosis.
    Williams TL; Day NC; Ince PG; Kamboj RK; Shaw PJ
    Ann Neurol; 1997 Aug; 42(2):200-7. PubMed ID: 9266730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of AMPA receptors and VEGF in ALS.
    Van Damme P
    Verh K Acad Geneeskd Belg; 2009; 71(4):241-50. PubMed ID: 20084835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effect of metabotropic glutamate receptor inhibition on amyotrophic lateral sclerosis-cerebrospinal fluid toxicity in vitro.
    Anneser JM; Chahli C; Borasio GD
    Neuroscience; 2006 Sep; 141(4):1879-86. PubMed ID: 16820266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Role of glutamate and excitotoxicity in neurologic diseases].
    Hugon J; Vallat JM; Dumas M
    Rev Neurol (Paris); 1996 Apr; 152(4):239-48. PubMed ID: 8763652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substance P receptor activation induces downregulation of the AMPA receptor functionality in cortical neurons from a genetic model of Amyotrophic Lateral Sclerosis.
    Caioli S; Curcio L; Pieri M; Antonini A; Marolda R; Severini C; Zona C
    Neurobiol Dis; 2011 Oct; 44(1):92-101. PubMed ID: 21726643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of selective motor neuronal death after exposure of spinal cord to glutamate: involvement of glutamate-induced nitric oxide in motor neuron toxicity and nonmotor neuron protection.
    Urushitani M; Shimohama S; Kihara T; Sawada H; Akaike A; Ibi M; Inoue R; Kitamura Y; Taniguchi T; Kimura J
    Ann Neurol; 1998 Nov; 44(5):796-807. PubMed ID: 9818936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered in-vitro and in-vivo expression of glial glutamate transporter-1 following exposure to cerebrospinal fluid of amyotrophic lateral sclerosis patients.
    Shobha K; Vijayalakshmi K; Alladi PA; Nalini A; Sathyaprabha TN; Raju TR
    J Neurol Sci; 2007 Mar; 254(1-2):9-16. PubMed ID: 17254611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late appearance of glutamate transporter defects in a murine model of ALS-parkinsonism dementia complex.
    Wilson JM; Shaw CA
    Neurochem Int; 2007 Jun; 50(7-8):1067-77. PubMed ID: 17095122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Excitotoxicity and neurodegeneration in amyotrophic lateral sclerosis.
    Rothstein JD
    Clin Neurosci; 1995-1996; 3(6):348-59. PubMed ID: 9021256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of excitatory amino acids in neuropathology].
    Wikinski SI; Acosta GB
    Medicina (B Aires); 1995; 55(4):355-65. PubMed ID: 8728878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AMPA receptor-mediated neuronal death in sporadic ALS.
    Kwak S; Hideyama T; Yamashita T; Aizawa H
    Neuropathology; 2010 Apr; 30(2):182-8. PubMed ID: 20102521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Excitatory amino acid receptors and neurodegeneration.
    Doble A
    Therapie; 1995; 50(4):319-37. PubMed ID: 7482387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased internalisation and degradation of GLT-1 glial glutamate transporter in a cell model for familial amyotrophic lateral sclerosis (ALS).
    Vanoni C; Massari S; Losa M; Carrega P; Perego C; Conforti L; Pietrini G
    J Cell Sci; 2004 Oct; 117(Pt 22):5417-26. PubMed ID: 15466883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Astrocytes regulate GluR2 expression in motor neurons and their vulnerability to excitotoxicity.
    Van Damme P; Bogaert E; Dewil M; Hersmus N; Kiraly D; Scheveneels W; Bockx I; Braeken D; Verpoorten N; Verhoeven K; Timmerman V; Herijgers P; Callewaert G; Carmeliet P; Van Den Bosch L; Robberecht W
    Proc Natl Acad Sci U S A; 2007 Sep; 104(37):14825-30. PubMed ID: 17804792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium mediated excitotoxicity in neurofilament aggregate-bearing neurons in vitro is NMDA receptor dependant.
    Sanelli T; Ge W; Leystra-Lantz C; Strong MJ
    J Neurol Sci; 2007 May; 256(1-2):39-51. PubMed ID: 17368487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonergic mechanisms in amyotrophic lateral sclerosis.
    Sandyk R
    Int J Neurosci; 2006 Jul; 116(7):775-826. PubMed ID: 16861147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mRNA expression of AMPA type glutamate receptors in the primary motor cortex of patients with amyotrophic lateral sclerosis: an in situ hybridization study.
    Petri S; Krampfl K; Hashemi F; Schmalbach S; Grothe C; Hori A; Dengler R; Bufler J
    Neurosci Lett; 2004 Apr; 360(3):170-4. PubMed ID: 15082160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 54.